Menu
Back to Journals » Vascular Health and Risk Management » Volume 12
Review
PCSK9 inhibition in the management of hyperlipidemia: focus on evolocumab
| Total article views | Abstract views | HTML views | PDF downloads | Totals | |
|---|---|---|---|---|---|
| 11,475 | Dovepress* | 5,605 | 2,699+ | 1,676 | 8,304 |
| PubMed Central* | 0 | 3,171 | 994 | 3,171 | |
| Totals | 5,605 | 5,870 | 2,670 | 11,475 | |
|
*Since 9 May 2016 +Since July 2016 |
|||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 8 | 0 | 0 | 0 | 3 | 5 |
View citations on PubMed Central and Google Scholar